Dr Jacqueline Hill of La Prairie explains the science and innovation behind the Swiss brand’s latest Pure Gold line.
The FDA has approved the combination of lurbinectedin (Zepzelca) and the immunotherapy atezolizumab (Tecentriq) for first-line maintenance treatment in patients with extensive-stage small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback